Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adherens junction 💬
1件: FGFR1 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
2 Adherens junction 💬
1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
3 Adherens junction 💬
1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
4 Adherens junction 💬
1件: FGFR1 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
5 Adherens junction 💬
1件: FGFR1 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
6 Breast cancer 💬
1件: FGFR1 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
7 Breast cancer 💬
1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
8 Breast cancer 💬
1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
9 Breast cancer 💬
1件: FGFR1 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
10 Breast cancer 💬
1件: FGFR1 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
11 Calcium signaling pathway 💬
1件: FGFR1 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
12 Calcium signaling pathway 💬
1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
13 Calcium signaling pathway 💬
1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
14 Calcium signaling pathway 💬
1件: FGFR1 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
15 Calcium signaling pathway 💬
1件: FGFR1 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
16 Central carbon metabolism in cancer 💬
1件: FGFR1 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
17 Central carbon metabolism in cancer 💬
1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
18 Central carbon metabolism in cancer 💬
1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
19 Central carbon metabolism in cancer 💬
1件: FGFR1 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
20 Central carbon metabolism in cancer 💬
1件: FGFR1 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
21 MAPK signaling pathway 💬
1件: FGFR1 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
22 MAPK signaling pathway 💬
1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
23 MAPK signaling pathway 💬
1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
24 MAPK signaling pathway 💬
1件: FGFR1 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
25 MAPK signaling pathway 💬
1件: FGFR1 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
26 Melanoma 💬
1件: FGFR1 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
27 Melanoma 💬
1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
28 Melanoma 💬
1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
29 Melanoma 💬
1件: FGFR1 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
30 Melanoma 💬
1件: FGFR1 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
31 Parathyroid hormone synthesis, secretion and action 💬
1件: FGFR1 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
32 Parathyroid hormone synthesis, secretion and action 💬
1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
33 Parathyroid hormone synthesis, secretion and action 💬
1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
34 Parathyroid hormone synthesis, secretion and action 💬
1件: FGFR1 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
35 Parathyroid hormone synthesis, secretion and action 💬
1件: FGFR1 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
36 Pathways in cancer 💬
1件: FGFR1 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
37 Pathways in cancer 💬
1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
38 Pathways in cancer 💬
1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
39 Pathways in cancer 💬
1件: FGFR1 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
40 Pathways in cancer 💬
1件: FGFR1 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
41 PI3K-Akt signaling pathway 💬
1件: FGFR1 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
42 PI3K-Akt signaling pathway 💬
1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
43 PI3K-Akt signaling pathway 💬
1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
44 PI3K-Akt signaling pathway 💬
1件: FGFR1 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
45 PI3K-Akt signaling pathway 💬
1件: FGFR1 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
46 Prostate cancer 💬
1件: FGFR1 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
47 Prostate cancer 💬
1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
48 Prostate cancer 💬
1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
49 Prostate cancer 💬
1件: FGFR1 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
50 Prostate cancer 💬
1件: FGFR1 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
51 Proteoglycans in cancer 💬
1件: FGFR1 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
52 Proteoglycans in cancer 💬
1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
53 Proteoglycans in cancer 💬
1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
54 Proteoglycans in cancer 💬
1件: FGFR1 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
55 Proteoglycans in cancer 💬
1件: FGFR1 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
56 Rap1 signaling pathway 💬
1件: FGFR1 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
57 Rap1 signaling pathway 💬
1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
58 Rap1 signaling pathway 💬
1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
59 Rap1 signaling pathway 💬
1件: FGFR1 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
60 Rap1 signaling pathway 💬
1件: FGFR1 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
61 Ras signaling pathway 💬
1件: FGFR1 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
62 Ras signaling pathway 💬
1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
63 Ras signaling pathway 💬
1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
64 Ras signaling pathway 💬
1件: FGFR1 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
65 Ras signaling pathway 💬
1件: FGFR1 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
66 Regulation of actin cytoskeleton 💬
1件: FGFR1 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
67 Regulation of actin cytoskeleton 💬
1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
68 Regulation of actin cytoskeleton 💬
1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
69 Regulation of actin cytoskeleton 💬
1件: FGFR1 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
70 Regulation of actin cytoskeleton 💬
1件: FGFR1 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
71 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR1 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
72 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
73 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
74 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR1 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
75 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR1 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
76 Thermogenesis 💬
1件: FGFR1 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
77 Thermogenesis 💬
1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
78 Thermogenesis 💬
1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
79 Thermogenesis 💬
1件: FGFR1 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
80 Thermogenesis 💬
1件: FGFR1 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬